Our study identifies PDLIM3 as a novel suppressor of EMT and metastatic ability in HNSCC, distinct from its oncogenic roles in gastric and medulloblastoma cancers. This evidence concerns the gene PDLIM3 and head and neck squamous cell carcinoma.